Ali Hammed S, Fadhil Alwan A. Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs. MECOJ [Internet]. 2025 Dec. 2 [cited 2026 Feb. 18];1(4):20-5. Available from: https://scientificsteps-group.com/ojs/ojs3/index.php/mecoj/article/view/189